Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

UCSF launches new initiative to propel the development of living therapeutics

UC San Francisco is launching a new initiative to propel the development of living therapeutics - a category of treatments broadly defined as human and microbial living cells that are selected, modified, or engineered to treat or cure disease - and bring them quickly to patients.

14 Jun 2021

COVID-19 in pregnancy could be less severe than previously thought: A Danish case study

A reassuring study by researchers in Denmark indicates that while 5% of pregnant women with COVID-19 may require hospitalization, severe maternal and neonatal outcomes are rare.

14 Jun 2021

UMass Amherst researcher receives NIH grant to study the impact of ACOs on asthma care for children

University of Massachusetts Amherst health services researcher Dr. Sarah Goff has received a $3 million grant from the National Institutes of Health to study the impact of accountable care organizations (ACOs) on asthma care for children insured by Medicaid.

9 Jun 2021

Study: COVID-19 produced more symptoms and complications than seasonal influenza in youths

A new global study of 30-day outcomes in children and adolescents with COVID-19 found that while death was uncommon, the illness produced more symptoms and complications than seasonal influenza.

8 Jun 2021

Chronic medical conditions could increase the risk of severe COVID-19 among children

...

7 Jun 2021

Mast cell activation may underlie inflammation in severe COVID-19

A new preprint research paper posted to the medRxiv* server points to mast cells as major culprits in the etiology of severe and critical COVID-19. This could suggest suitable therapeutic and preventive interventions to reduce the morbidity and mortality of this viral illness.

3 Jun 2021

Study reveals prevalence of multimorbidity among people using methamphetamine

People who use methamphetamine are more likely to have health conditions, mental illness, and substance use disorders than people who do not use the drug, according to a new study by researchers at the Center for Drug Use and HIV/HCV Research (CDUHR) at NYU School of Global Public Health.

3 Jun 2021

Long COVID patients at higher risk of small airway disease

The preprint discussed herein describes the effects of SARS-CoV-2 on lung structure and function in patients with long COVID.

2 Jun 2021

Methamphetamine users more susceptible to have medical, mental, and substance use issues

People who use methamphetamine are nearly twice as likely to have medical multimorbidity, and over three times as likely to have a mental illness.

2 Jun 2021

FIRS calls on governments and policymakers to support and promote tobacco cessation services

On World No Tobacco Day (31 May, 2021) the Forum of International Respiratory Societies (FIRS), of which the American College of Chest Physicians® (CHEST) is a founding member, calls on governments and policymakers to make greater political and financial commitments to support and promote tobacco cessation services.

29 May 2021

Can acetaminophen use during pregnancy increase the risk of ADHD and autism symptoms in children?

In a new study, researchers confirmed that the use of paracetamol during pregnancy led to an increased risk of children displaying symptoms of ADHD and autism.

28 May 2021

Study shows CoronaVac to have high seroconversion rate after 40 days

Researchers from the Federal University of Paraná, Brazil, looked into the seroconversion rate after vaccination with the CoronaVac. Using immunoassays, they measured the immunoglobulins (IgG) for anti-nucleocapsid protein (anti-N) antibodies and anti-spike-1 (anti-S1) protein antibodies.

27 May 2021

Enrolment in high-deductible health plan may not be linked to asthma exacerbations

How does the switch to a high-deductible health plan affect children with asthma? A new study led by researchers at the Harvard Pilgrim Health Care Institute suggests that enrollment in a high-deductible health plan (HDHP) may not be associated with changes in asthma medication use or asthma exacerbations when medications are exempt from the deductible.

26 May 2021

Shared genetic architecture between COVID-19 severity and other health conditions

Researchers in the United States have identified a shared genetic architecture between coronavirus disease 2019 (COVID-19) severity and other health conditions.

24 May 2021

Are COVID-19 medications safe in pregnancy?

Most medications being tested today in clinical trials for the treatment of coronavirus disease 2019 (COVID-19) have been repurposed from other indications. These are typically not tested in pregnant women. A new study, published in the journal PLOS ONE, summarizes what is known about the safety of these drugs in this group.

24 May 2021

Study could lead to new antibiotics to fight bacterial infections

One member of a large protein family that is known to stop the spread of bacterial infections by prompting infected human cells to self-destruct appears to kill the infectious bacteria instead, a new study led by UT Southwestern scientists shows.

21 May 2021

Prenatal exposure to air pollution can cause asthma in children

Women who were highly exposed to ultra-fine particles in air pollution during their pregnancy were more likely to have children who developed asthma, according to a study published in the American Journal of Respiratory and Critical Care Medicine in May.

21 May 2021

Asthma patients can benefit from type 2 diabetes medication

Type 2 diabetes patients who also have asthma are benefitting from a diabetes medication, typically given to help the pancreas produce more insulin, that also improves asthma symptoms and may reduce lung and airway inflammation.

21 May 2021

Plastic chemicals can induce changes in gene that is vital for neurological development

The chemical bisphenol F (found in plastics) can induce changes in a gene that is vital for neurological development. This discovery was made by researchers at the universities of Uppsala and Karlstad, Sweden.

20 May 2021

Dupilumab considerably reduced asthma exacerbations in young children, shows VOYAGE trial

Results from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages 6-11 with uncontrolled moderate-to-severe asthma, compared to placebo, according to research presented at the ATS 2021 International Conference. VOYAGE (NCT02948959) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial, that took place in a number of countries.

20 May 2021

Asthma News and Research

Further Reading

UCSF launches new initiative to propel the development of living therapeutics

COVID-19 in pregnancy could be less severe than previously thought: A Danish case study

UMass Amherst researcher receives NIH grant to study the impact of ACOs on asthma care for children

Study: COVID-19 produced more symptoms and complications than seasonal influenza in youths

Chronic medical conditions could increase the risk of severe COVID-19 among children

Mast cell activation may underlie inflammation in severe COVID-19

Study reveals prevalence of multimorbidity among people using methamphetamine

Long COVID patients at higher risk of small airway disease

Methamphetamine users more susceptible to have medical, mental, and substance use issues

FIRS calls on governments and policymakers to support and promote tobacco cessation services

Can acetaminophen use during pregnancy increase the risk of ADHD and autism symptoms in children?

Study shows CoronaVac to have high seroconversion rate after 40 days

Enrolment in high-deductible health plan may not be linked to asthma exacerbations

Shared genetic architecture between COVID-19 severity and other health conditions

Are COVID-19 medications safe in pregnancy?

Study could lead to new antibiotics to fight bacterial infections

Prenatal exposure to air pollution can cause asthma in children

Asthma patients can benefit from type 2 diabetes medication

Plastic chemicals can induce changes in gene that is vital for neurological development

Dupilumab considerably reduced asthma exacerbations in young children, shows VOYAGE trial

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News